28 results
Industry
Industry
Adoption
Environment
PROJECT NUMBER • 2019-005
PROJECT STATUS:
COMPLETED

Risk analysis to identify and minimise biosecurity risks arising from recycling bivalve mollusc shell waste during shellfish reef restoration projects in Australia

The assessment indicated that heating recycled mollusc shells in water to 80°C for at least 5 minutes would meet the ALOP for all diseases (despite uncertainly for some disease agents due to lack of information, as indicated by ?), and was within the ALOP for all pests of concern. This method...
ORGANISATION:
DigsFish Services Pty Ltd
Industry
PROJECT NUMBER • 2018-102
PROJECT STATUS:
COMPLETED

Understanding Ostreid herpesvirus type 1 risk: alternative hosts and in situ hybridisation

South Australia (SA) has a large edible oyster industry primarily growing Pacific oysters (Crassostrea gigas). The industry is regionally-based, an important employer and a substantial contributor to regional economies. Pacific oyster mortality syndrome (POMS) is a serious infectious disease of C....
ORGANISATION:
Flinders University
Industry
PROJECT NUMBER • 2017-203
PROJECT STATUS:
COMPLETED

Risk from Diarrhetic Shellfish Toxins and Dinophysis to the Australian Shellfish Industry

This study first examined DSTs in spiked and naturally contaminated shellfish - Sydney Rock Oysters (Saccostrea glomerata), Pacific Oysters (Magallana gigas/Crassostrea gigas), Blue Mussels (Mytilus galloprovincialis) and Pipis (Plebidonax deltoides/Donax deltoides), using LC-MS/MS ...
ORGANISATION:
University of Technology Sydney (UTS)
Environment
PROJECT NUMBER • 2016-023
PROJECT STATUS:
COMPLETED

Sentinel sensors: revolutionising our understanding and management of the estuarine environment

This study, undertaken by CSIRO Oceans and Atmosphere, examines the usefulness of mussels as sentinels for environmental change using a novel biosensor. This project measured the vital signs of heart rate and behaviour in sentinel animals, as they respond to multiple and interacting changes in the...
ORGANISATION:
CSIRO Oceans and Atmosphere Hobart

Assessing occurrence of pathogenic species of the marine bacteria Vibrio in Tasmanian oysters from St Helens

Project number: 2015-042
Project Status:
Completed
Budget expenditure: $29,520.38
Principal Investigator: Tom Madigan
Organisation: SARDI Food Safety and Innovation
Project start/end date: 29 Feb 2016 - 29 Jun 2016
Contact:
FRDC

Need

This is the first time that an illness associated with Vibrio has been traced-back to Tasmanian oysters. Regrettably, this incident occurred in the only major harvesting area in Tasmania that has not been impacted by the current Pacific oyster mortality event.

In Australia the control of Vibrio is currently limited to temperature controls during storage or transport. Pre-harvest controls used by the shellfish quality assurance programs are predicated on controlling risk posed by faecal contamination and biotoxins and are not suitable for controlling risk from these naturally occurring bacteria. Although the recent implementation of the Codex Standard for pathogenic marine vibrios suggests risk in bivalve growing areas should be assessed to ascertain the risk to public health, there has been limited research undertaken in Australia. The studies undertaken to date have generally been short in nature with no comprehensive longitudinal studies being undertaken and methodologies have now progressed significantly, whereas New Zealand has been undertaking a long-term survey to understand the risk posed by these pathogens (Cruz, Hedderley & Fletcher 2015). This issue may become a risk in accessing key markets that are active in monitoring or who regulate for these pathogens.

There is an immediate need to collect information on prevalence for the remainder of the summer period to understand the risk and evaluate if there is a relationship to salinity, temperature and toxic strains. This information will be immediately useful for developing appropriate management plans in this growing region.

This illness outbreak will likely result in Tasmanian Shellfish Quality Assurance Program and the other state programs having to consider how to manage risk in the growing areas and establish what is an acceptable level. The work proposed here could be used as a framework for future work that assesses risk across the bivalve industry Australia-wide.

Objectives

1. Assess for the prevalence of pathogenic Vibrio species in the St Helens harvesting region
2. Assess for the presence of genes associated with virulence in Vibrio parahaemolyticus
3. Evaluate if a relationship exisits that between prevalance and sea water temperature and salinity

Final report

ISBN: 978-1-921563-92-8
Authors: Tom Madigan Kate Wilson Gayle Smith and Alison Turnbull

Improved understanding of Tasmanian harmful algal blooms and biotoxin events to support seafood risk management

Project number: 2014-032
Project Status:
Completed
Budget expenditure: $600,000.00
Principal Investigator: Gustaaf Hallegraeff
Organisation: University of Tasmania (UTAS)
Project start/end date: 31 Jul 2014 - 31 Dec 2017
Contact:
FRDC

Need

The 2012 Tasmanian biotoxin event represents a paradigm shift for seafood risk management in Tasmania and Australia as a whole. The causative dinoflagellates are extremely difficult to identify by routine plankton monitoring, and are toxic at very low cell concentrations (50-100 cells/L) . Sampling the extensive Tasmanian coast line poses a major logistical challenge, with early hints that the blooms originate offshore. The precise pathway of toxin transfer to rock lobster is unclear. The presence of cyst beds suggest that problems will persist .

Objectives

1. Develop, test and calibrate screening techniques for rapid detection and evaluation of toxins
2. Elucidate genetic population structure and biology (inshore or offshore origin) of toxic Alexandrium tamarense- group algae using state-of-the art molecular and biotoxin screening techniques
3. Integrate existing Tasmanian east coast oceanographic modeling with field bloom biology data to enable seasonal and spatial (risk zone) prediction during biotoxin event development.
4. Establish the relative risk of Tasmanian seafood species to accumulate marine biotoxins to underpin a state-wide approach to biotoxin risk management.

Final report

ISBN: 978-1-925646-08-5
Authors: Gustaaf Hallegraeff Chris Bolch Katrina Campbell Scott Condie Juan Dorantes-Aranda Shauna Murray Alison Turnbull Sarah Ugalde
Final Report • 2018-02-28 • 18.01 MB
2014-032-DLD.pdf

Summary

The 2012 Tasmanian biotoxin event represents a paradigm shift for seafood risk management in Tasmania and Australia as a whole. The causative dinoflagellates are extremely difficult to identify by routine plankton monitoring, and are toxic at very low cell concentrations (50-100 cells/L). Sampling the extensive Tasmanian coast line poses a major logistical challenge. This project sought to improve the understanding of Tasmanian harmful algal bloom biology, ecology and toxicology to support seafood biotoxin risk management.

Industry
PROJECT NUMBER • 2013-711.40
PROJECT STATUS:
COMPLETED

Seafood CRC: new opportunities for seafood processing waste

This report summarises the research undertaken under FRDC 2013/711.40: New Opportunities for Seafood Processing Waste Industry consultation and the development of a modified value chain analysis framework for new products from processing waste resulted in eleven industry case studies being...
ORGANISATION:
Curtin University

Tackling a critical industry bottleneck: developing methods to avoid, prevent and treat biofouling on mussel farms

Project number: 2010-202
Project Status:
Completed
Budget expenditure: $299,998.30
Principal Investigator: Michael J. Keough
Organisation: University of Melbourne
Project start/end date: 31 Dec 2010 - 8 Sep 2014
Contact:
FRDC

Need

Biofouling has emerged as the main bottleneck to production in the mussel farming industry. For example, since 2003, mussel production has declined by approximately 50% in Victoria. Concurrent with this decline has been the rise of several problematic biofouling species, including the invasive hydroid (Ectopleura crocea), the invasive sea star (Asterias amurensis), and several ascidian and algal species. Many of these biofouling taxa are common across Victorian, South Australian, Western Australian, Tasmanian and New South Wales mussel farms. Combined, these biofouling species are believed to have had a range of effects on production, including: 1) reducing natural mussel spat settlement rates; 2) preying upon mussel spat and juveniles; 3) competing for food with mussels; and 4) smothering established mussels.

A clear need exists to develop methods to avoid, prevent and treat biofouling to reduce costs and improve production. Typically, biofouling management accounts for 30-40% of production costs. Current biofouling removal methods (stripping of lines or fresh-water baths) are time consuming and labour-intensive. As a consequence, biofouling often develops to damaging levels before farmers are able to remove it.

Farmers require knowledge of the timing, location and depth of key fouling species so biofouling outbreaks can be avoided. Further, there is a need to test whether the type of equipment used (e.g., rope type and colour) or its arrangement (dropper spacing and dropper depth) may reduce biofouling. As some biofouling will inevitably develop on mussel lines, new biofouling treatments that are cheap, easy to use and effective must be tested. These include acetic acid, hot water baths, high pressure hot air and their combinations. Acetic acid has proved promising against many biofouling species in the New Zealand mussel industry, but has not been trialled on key biofouling species in southern Australian waters (e.g. hydroids).

Objectives

1. Measure the effects of key biofouling species on mussel spat survival and grow-out.
2. Test farm management methods that will discourage and/or avoid biofouling episodes.
3. Test the effectiveness of existing and new biofouling treatment methods to develop cost-efficient, implementable, on-farm treatments.
4. Measure the effects of key biofouling species on mussel spat survival and grow-out.

Final report

ISBN: 978 0 7340 5016 8
Author: Michael Keough
Final Report • 2014-08-01 • 25.78 MB
2010-202-DLD.pdf

Summary

Biofouling negatively affects shellfish production through several pathways, including: 1) reducing natural mussel spat settlement rates; 2) preying upon mussel spat and juveniles; 3) competing for food with mussels; and 4) smothering established mussels. These problems are well documented in the culture of other bivalves such as oysters and scallops, where water flow is restricted to such an extent by fouling organisms that the availability of food and growth of stock are impeded (Claereboudt et al. 1994; Taylor et al. 1997). However, the effects of fouling organisms in long-line mussel culture remain poorly known (LeBlanc et al. 2003). Various native ascidians, hydroids, tunicates, macroalgae and seastars are common biofoulers across the mussel farming industry in Australia’s southern waters. In Victoria, as in other parts of the world, introduced species are also emerging as key pests. 

At present, Australian farmers deal with biofouling reactively, with treatment strategies implemented only after outbreaks have occurred. Current treatment protocols are largely based on a 2001 study in Victoria investigating measures to reduce the risk of moving noxious aquatic species via aquaculture stock or equipment (Gunthorpe 2001). Individual farmers have tried several methods on an ad-hoc basis to try to manage their fouling loads but they do not have the time or resources to carry out rigorous scientific testing and trials. Similarly, they are not aware of the basic biology or life history of the fouling species they are dealing with, and have no documented monitoring program in place to assess when fouling episodes are to be expected, and what species to be on the lookout for. Effective strategies to control biofouling must integrate information over the complex of biofouling species and their various effects. As fouling will always develop on mussel lines, it is important to develop and test cheap, easy to implement on-farm treatments that are effective against a range of biofouling species that do not affect mussel production.

Project products

Guide • 8.65 MB
Biofouling Management Guidelines for Mussel Culture Handbook.pdf

Summary

This guide was written utilising information from FRDC project 2010-202: Tackling a critical industry bottleneck - developing methods to avoid, prevent and treat biofouling on mussel farms.

The research was funded by the FRDC on behalf of the Australian Government.

Seafood CRC: overseas market access for shellfish

Project number: 2009-752
Project Status:
Completed
Budget expenditure: $5,000.98
Principal Investigator: Catherine McLeod
Organisation: SARDI Food Safety and Innovation
Project start/end date: 31 Aug 2009 - 30 Nov 2009
Contact:
FRDC

Need

The potential reduction of regulatory thresholds for marine biotoxins in the EU will have significant negative economic consequences for the Australian oyster, mussel, scallop and abalone industries (and pipi’s if domestic regulatory thresholds also changed).

The scallop, oyster and mussel industry currently export product to the EU. Total scallop exports to the EU in 2006/2007 were valued at around $4,551,000 AUD (187 t). Other mollusc (including oysters and mussels) exports to the EU in 2006/2007 were around $1,084,000 AUD (255 t). Due to the periodic occurrence of okadaic acid toxins and saxitoxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for export to the EU.

Exports of Australian abalone to the EU ceased in 2007, this was in part due to the enforcement of marine biotoxin regulatory limits by the EC. The wild caught abalone industry is attempting to regain market access to the EU through determining alternate risk management procedures for marine biotoxins in abalone. The reduction of regulatory levels for marine biotoxins may impinge on future EU access arrangements for Australian abalone.

Experience has repeatedly demonstrated that European decisions can impact on other more commercially significant markets, including Asia and the domestic market. Codex may also be prompted to change marine biotoxin guidance levels in response to EU changes. Wide spread adoption of reduced regulatory levels for marine biotoxins would result in increased growing area closures in Australia and less product eligible for sale. This proposal aims to assist in maintaining the current EU regulatory limits for marine biotoxins which will allow the current amount of shellfish to be exported to the EU and avoid other markets being influenced.

Objectives

1. Undertake robust technical review of the European Food Safety Authority risk assessments on saxitoxin and okadaic acid group toxins.
2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the European Commission.
3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.

Final report

ISBN: 978-0-9756044-8-9
Authors: Dr Catherine McLeod Dr John Sumner Dr Andreas Kiermeier
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.
Final Report • 2011-02-24 • 1.18 MB
2009-752-DLD.pdf

Summary

The oyster, scallop and mussel industries currently export product to the EU. Due to the periodic occurrence of Okadaic Acid (OA) and Saxitoxin (STX) group toxins in Australian shellfish the implementation of reduced regulatory levels would reduce the amount of product eligible for EU export. Exports of Australian abalone to the EU ceased in 2007, due in part to the enforcement of marine biotoxin regulatory limits set by the EC. The wild caught abalone industry is attempting to regain EU market access through determining alternate risk management procedures for marine biotoxins in abalone.

The European Commission (EC) requested the European Food Safety Authority (EFSA) to assess the current European Union (EU) limits for shellfish regarding human health and methods of analysis for various marine biotoxins, including newly emerging toxins. A critical recommendation of the ‘EFSA Opinions’ is that the regulatory limits should be significantly lower (more stringent) for both OA and STX.

The objectives of this study were to:

  1. Undertake a robust technical review of the EFSA risk assessments on STX and OA group toxins.
  2. Submit the technical review and a rationale for maintaining current marine biotoxin regulatory limits to the EC.
  3. Convene a working group to determine future steps required to mitigate potential lowering of marine biotoxin regulatory limits.

Australian Mussel Association - formation and levy setup

Project number: 2008-224
Project Status:
Completed
Budget expenditure: $61,446.00
Principal Investigator: Ewan A. Colquhoun
Organisation: Ridge Partners
Project start/end date: 31 Aug 2008 - 29 Jun 2009
Contact:
FRDC

Need

Aquaculturists, fishers and seafood producers must be increasingly sophisticated to secure and manage their access rights to natural resources, positively respond to community interest in their activities, and viably compete in domestic and overseas markets. As a small emerging sector mussel growers currently have no aggregate capacity to address these risks relevant to their industry. Resolution of these challenges is increasingly beyond the scope of any single mussel enterprise or regional / state based group of interests.

A national industry body is a critical first step to promote effective industry and stakeholder communication, enable representation of grower and stakeholder views, develop knowledge and strategic direction and related action plans, enable cost effective investment in and management of reserch and development funds, and facilitate industry's growth. As an emerging sector, the mussel industry currently has no formal plans or development strategies.

Emerging sectors also suffer from lack of funds to grow their businesses and conduct critical research that will deliver market competitive advantages. They also need to overcome the market failure that accompanies early stage investment in shared research outcomes. By working with groups of national producers, the FRDC can provide and / or facilitate very cost effective pools of R&D funding, and a secure and pragmatic platform for industry members to jointly invest in, manage, and share the benefits of critical R&D.

Objectives

1. Establish a national mussel industry body
2. Establish a cost effective R&D investment platform

Towards reliable hatchery-produced quality blue mussels: an integrated approach to optimising supply

Project number: 2008-202
Project Status:
Completed
Budget expenditure: $287,876.00
Principal Investigator: Chris J. Bolch
Organisation: University of Tasmania (UTAS)
Project start/end date: 30 Sep 2008 - 29 Sep 2011
Contact:
FRDC

Need

Tasmania in 2005/06 was the largest producer of mussels in Australia; 31% of production and 42% of dollar value. This represents a three-fold increase in production and value of mussels in Tasmania over the past three years. Further to this, Spring Bay Seafoods is Australia largest mussel producer and processor; with consider capital investment into mussel production and processing. This project will directly address the issues of high and unpredictable mortality rates of blue mussel seed during the early nursery phase. There is a need in the hatcheries to develop techniques and approaches that maximise production of quality mussel seed, through informed decisions about how physical and biological conditions in the hatchery affect the health and growth of spat.

World-wide, mussel aquaculture ventures are largely supported by collection of wild juveniles. Several commercial shellfish hatcheries, in USA and Australia, produce small numbers of juvenile mussels to supplement wild collections. Until recently the demand and value of mussels has been too poor to warrant large scale hatchery production, and most shellfish hatcheries focus on higher value species, or species for which wild collection of juveniles is not possible, eg introduced oysters. Collection of spat from the wild imposes critical limits to the capacity of the mussel aquaculture industry to increase production and to control product quality and timing of supply to markets. Reliance on wild spat leaves the industry vulnerable to recruitment failure and restricts production to seasonal availability. In recent years there has been insufficient wild spat settlement to meet the demands of the expanding Tasmanian aquaculture mussel industry. The only way that the mussel industry can begin to compete against imported products and allow Australian consumers access to Australian product is through reliable hatchery production of quality-assured spat.

Objectives

1. To improve reliability and nutritional quality of live food production for juvenile mussels.
2. To assess the effect of the nutritional status of pre-settlement mussels on rates of spat settlement, retention, growth, and survival
3. To identify biological and physical factors that affect rates of spat settlement, retention, survival, and growth in land-based nursery systems
4. To adapt and assess the value of a stress test as a tool to assess quality of spat at the end of the land-based nursery phase.
5. To determine and identify changes in Vibrio composition and numbers associated with mortality events in mussel spat.

Final report

ISBN: 978-1-86295-711-4
Author: Chris Bolch
People
PROJECT NUMBER • 2002-652
PROJECT STATUS:
COMPLETED

Aquatic Animal Health Subprogram: enhancement of the emergency disease management capability in Victoria - developing a Victorian Control Centres Management Manual

AQUAVETPLAN and its associated manuals, and in particular the ‘AQUAVETPLAN Control Centres Management Manual’ provide the necessary framework for the development of a Victorian management/operational manual that would meet the planning needs in relation to aquatic animal diseases. The...
ORGANISATION:
Agriculture Victoria

Improving Post Harvest Handling to add value to farmed mussels

Project number: 2002-418
Project Status:
Completed
Budget expenditure: $29,600.00
Principal Investigator: Nick Ruello
Organisation: Ruello and Associates Pty Ltd
Project start/end date: 30 Jan 2003 - 30 Mar 2004
Contact:
FRDC

Need

There is a number of mussel farmers who have little knowledge on size grading and grading of mussels in relation to a condition index so that only good mussels with a satisfactory quality and shelf life are forwarded to market.
There is a need to identify the key quality and marketing parameters to prepare product specification for premium and standard grade mussels as a prerequisite for the development of a Code of Practice to guide growers, packers and marketers. This Code needs to cover handling, grading, packing, storage and transport of mussels to maximise quality and safety, shelf life and value of the mussels for industry and consumers benefit. This would reduce the amount of poor quality mussels going to market and thereby help raise overall prices for producers and reduce the wastage experienced today with poor mussels.
Wholesalers, retailers and restaurateurs need reliable information on how they should handle and store mussels to maximise quality and consumer benefit.

Objectives

1. Identify the key quality and marketing parameters for chilled mussels and prepare product specifications for premium and standard mussels.
2. Develop a Code of Practice which takes account of product labelling, uniform size grading, shell fouling and cleanliness, condition index and food safety requirements.
3. Prepare a small Mussel Users Handling Guide for wholesalers, retailers and restaurateurs.

Final report

ISBN: 0-9577695-12
Author: Nick Ruello
Final Report • 2004-07-20 • 1.07 MB
2002-418-DLD.pdf

Summary

The post harvest handling of farmed blue mussels, from the sea farm through to the retail store and restaurant was examined in 2003 in a national study funded by Seafood Services Australia and the Australian mussel farming industry.

The Objectives of the study were to: (a) Identify the key quality and marketing parameters for chilled mussels and prepare product specifications for “premium” and “standard” mussels (b) Develop a Code Of Practice which takes account of product labelling, uniform size grading, shell fouling and cleanliness, condition index and any mandatory food safety requirements for the guidance of all industry sectors and (c) prepare a product Trade Users Guide for wholesalers, retailers and restaurateurs.

The project was designed to reduce the volume of poor quality mussels going to market and thereby help raise overall prices for producers and to reduce the wastage experienced by the industry and consumers with poor quality mussels.

Desk research was also carried out to explore the basis of the advice commonly given by cookery writers to discard mussels which do not open after cooking. This warning has led to the waste of many mussels and generated much confusion amongst many trade users and consumers. Cooking tests were undertaken to examine the validity of this advice and to develop a simple method for assessing the “meat content” or Mussel Condition Index.

View Filter

Species